Skip to main content

What the FDA labels say about taking them together

Olanzapine and rifampin

Olanzapine's FDA label of March 5, 2026 names rifampin in its drug interactions section; the rifampin label PlainMeds reads does not name olanzapine. The olanzapine label: “Inducers of CYP1A2 or Glucuronyl Transferase – Omeprazole and rifampin may cause an increase in olanzapine clearance.”

Check it at the source: the olanzapine FDA label on DailyMed (effective March 5, 2026, Macleods Pharmaceuticals Limited); the rifampin FDA label on DailyMed (effective February 11, 2026, Lupin Pharmaceuticals, Inc.).

What does the olanzapine label say about rifampin?

Olanzapine label, drug interactions

Inducers of CYP1A2 or Glucuronyl Transferase – Omeprazole and rifampin may cause an increase in olanzapine clearance.

Source: FDA drug label (Zyprexa Relprevv, NDA022173), H2-Pharma LLC, effective May 19, 2026 (SPL set 11544cba-64a9-49cb-8d74-da228053b252), via openFDA

Source: FDA drug label (Olanzapine), Macleods Pharmaceuticals Limited, effective March 5, 2026 (SPL set 8e095987-bdea-42f2-9550-c7155cf07d30), via openFDA; the full label on DailyMed

What does the rifampin label say about olanzapine?

Rifampin's label (effective February 11, 2026) does not name olanzapine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (rifampin), Lupin Pharmaceuticals, Inc., effective February 11, 2026 (SPL set b56004f0-f23d-47f6-80c7-39884fccbccc), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

43Olanzapine generic labelers
13Rifampin generic labelers
OlanzapineRifampin
Labeled forSchizophrenia, Bipolar disorder, Depressionn/a
Boxed warningYesNo
Pharmacy cost (NADAC)$0.147 per tablet 20 mg tablet$0.679 per capsule 300 mg capsule
Shortage nowNo current entryIn shortage

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?